[IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria].

Maladie associée aux IgG4 : des critères « diagnostiques » aux critères de classification ACR/EULAR 2019.

Journal

La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 20 03 2020
revised: 28 05 2020
accepted: 20 06 2020
pubmed: 1 8 2020
medline: 23 2 2021
entrez: 1 8 2020
Statut: ppublish

Résumé

The concept of IgG4-related disease (IgG4-RD) has recently been individualized in the early 2000s, but most of the organ involvements are known since more than 100 years. IgG4-RD is a non-malignant fibroinflammatory disorder, characterized by peculiar immunological and pathological abnormalities, which can affect virtually all organs or tissues. Diagnostic criteria have been proposed and have evolved rapidly, with general or organ specific criteria. An international and multidisciplinary group assembled by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) has recently developed and validated a set of classification criteria called 2019 ACR/EULAR classification criteria for IgG4-related disease. The objective of this review is to discuss the evolution from organ specific and general diagnostic criteria toward the 2019 ACR/EULAR classification criteria, as well as respective benefits and limits of these criteria. The use of the 2019 ACR/EULAR classification criteria will help to better define homogeneous group of IgG4-RD patients in future clinical, epidemiological and basic science research studies on the disease.

Identifiants

pubmed: 32732082
pii: S0248-8663(20)30241-1
doi: 10.1016/j.revmed.2020.06.015
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

814-821

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

N Schleinitz (N)

Département de médecine interne, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.

A Briantais (A)

Département de médecine interne, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.

M Ebbo (M)

Département de médecine interne, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Aix Marseille Université, Marseille, France. Electronic address: mikael.ebbo@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH